Feasibility Study for Online Mindfulness for GAD

August 28, 2023 updated by: Lee Kam Pui, Chinese University of Hong Kong

Feasibility and Acceptability of an Evidence-based Mindfulness Online Resources for Patients With Generalized Anxiety Disorder

Method: . Forty patients with general anxiety disorder will be randomized in 1:1 ratio to the online resource plus usual care, and to usual care control group by stratified block randomization. Measurements including 7-item Generalized Anxiety Disorder questionnaire, 9-item Patient Health Questionnaire, Penn State Worry questionnaire, and Five Facet Mindfulness Questionnaire will be made at baseline and at 2-month. Rate of recruitment, drop out and website usage will be collected. All patients in the intervention arm will be interviewed to assess the clarity of the app and user experience. The scores between the two arms will be compared by t-test and the transcripts of the patient interviews will be analysed using thematic analysis

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • School of public health and primary care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • received a diagnosis of GAD in the computerized record system (CMS) in Hong Kong hospital authority
  • score ≥10 on the 7-item Generalized Anxiety Disorder scale (GAD-7), signifying active moderate anxiety symptoms
  • used any website in prior 12 months
  • received stable dose of psychoactive medications in last 2 months

Exclusion Criteria:

  • any diagnosed psychotic disorder
  • diagnosis of dementia
  • any diagnosed substance abuse disorder (except smoking)
  • active suicidal ideation (score ≥1 on 9-item Patient Health Questionnaire
  • had regular mindfulness meditation practice in last 6 months or had participated in MBSR/MBCT course

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: online mindfulness resources + usual care
The mindfulness online resources consisted of 4 weekly modules. Mindfulness exercises, including body scan, mindful breathing, mindful eating, mindful walking, 3-min breathing space, and thought distancing exercise, are audio-recorded to facilitate participants to practice mindfulness. Readings and graphics are included to explain the concept of mindfulness and to share with participants the common difficulties that participants may come across during mindfulness practices.
a free mindfulness resource online for patients with general anxiety disorder
Other: usual care
patients will receive usual care from doctors
patient will continue to receive drug and advice from doctors and nurses for their anxiety disorder

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
recruitment rate
Time Frame: through study completion, an average of 1 year
rate of recruitment during the trial period
through study completion, an average of 1 year
dropout rate
Time Frame: through study completion, an average of 1 year
rate of dropout during the trial period
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
7-item Generalized Anxiety Disorder questionnaire
Time Frame: baseline and 2-month
a validated questionnaire to measure anxiety symptoms. Possible score ranged from 0-21. the higher the score, the more severe the anxiety symptoms
baseline and 2-month
9-item Patient Health Questionnaire
Time Frame: baseline and 2-month
a validated questionnaire to measure anxiety symptoms. Possible score ranged from 0-27. the higher the score, the more severe the depressive symptoms
baseline and 2-month
Penn State Worry Questionnaire
Time Frame: baseline and 2-month
a validated questionnaire to measure worry. The possible score ranged from 16-80. the higher the score, the more severe the worries
baseline and 2-month
Five Facet Mindfulness Questionnaire
Time Frame: baseline and 2-month
a validated questionnaire to measure mindfulness. The possible score ranged from 1-5. the higher the score, the more mindful the participants are
baseline and 2-month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2021

Primary Completion (Actual)

October 31, 2022

Study Completion (Actual)

October 31, 2022

Study Registration Dates

First Submitted

September 13, 2021

First Submitted That Met QC Criteria

September 16, 2021

First Posted (Actual)

September 28, 2021

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020.385

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

will share on a reasonable request from other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety Generalized

Clinical Trials on online mindfulness resources

3
Subscribe